Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Open Heart ; 4(1): e000591, 2017.
Article in English | MEDLINE | ID: mdl-28409014

ABSTRACT

BACKGROUND: The effects of antihypertensive drug combination therapy on central blood pressure (BP) and augmentation index (AI) have not been fully elucidated. We investigated the effects of the direct renin inhibitor, aliskiren, or a diuretic added to an angiotensin II receptor blocker on AI in patients with essential hypertension. METHODS: A 24-week, prospective, multicentre, randomised, open-label study enrolled 103 patients already treated with valsartan. Participants were randomly allocated to receive either valsartan with aliskiren (V+A), or valsartan with trichlormethiazide (V+T). The primary outcome was the change in AI derived from radial artery tonometry. Secondary outcome measures included systolic and diastolic BP, cardio-ankle vascular index (CAVI, which reflects arterial stiffness) and urinary 8-hydroxydeoxyguanosine concentration. RESULTS: After 24 weeks, systolic and diastolic BP were significantly reduced in both groups to a broadly comparable extent. There was no significant difference in AI at the end of the study between the V+A group and the V+T group (between-group difference: -2.3%, 95% CI -6.9% to 2.2%, p=0.31). Central BP at the end of the study also did not differ between the two groups (p=0.62). There was no significant difference in the CAVI between the groups at the end of the study. Urinary 8-hydroxydeoxyguanosine concentration was significantly lower in the V+A group than in the V+T group (p<0.01), suggesting that V+A attenuated oxidative stress more than V+T. CONCLUSION: The combination of valsartan and aliskiren had an effect on AI comparable with that of the combination of valsartan and trichlormethiazide. UMIN CLINICAL TRIAL REGISTRATION NUMBER: UMIN000005726.

2.
Clin Exp Hypertens ; 32(4): 221-6, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20608892

ABSTRACT

We examined the relationships between home blood pressure (BP) and atmospheric temperature in 20 treated-hypertensive patients. A significant correlation between morning and evening BP and atmospheric temperature was found. For morning systolic blood pressure (SBP), the maximal seasonal difference was 13.2 mmHg with 25.5 degrees C temperature difference. Morning SBP increased by approximately 0.41 mmHg with a 1 degrees C decrease in atmospheric temperature. A similar but weaker correlation with temperature was observed for morning diastolic, evening systolic and diastolic blood pressure (DBP). The present study provides important information in respect to BP changes with atmospheric temperature that should be taken into account in the analysis and treatment of hypertension.


Subject(s)
Antihypertensive Agents/therapeutic use , Blood Pressure Monitoring, Ambulatory/methods , Blood Pressure/drug effects , Hypertension/drug therapy , Hypertension/physiopathology , Outpatients , Temperature , Aged , Algorithms , Circadian Rhythm , Female , Humans , Hypertension/diagnosis , Male , Middle Aged , Models, Statistical , Retrospective Studies , Seasons
3.
Cardiology ; 113(2): 138-45, 2009.
Article in English | MEDLINE | ID: mdl-19039222

ABSTRACT

OBJECTIVE: The augmentation index, a marker of wave reflection, has been reported to reflect vascular properties and to determine left ventricular (LV) characteristics. We investigated the relationship between the augmentation index and paroxysmal atrial fibrillation (AF). METHODS: A total of 244 outpatients (122 patients with paroxysmal AF and 122 age-, and gender-matched controls without paroxysmal AF) were examined during sinus rhythm. The augmentation index was calculated from the radial arterial waveform using applanation tonometry methods. RESULTS: After adjusting for age, gender, heart rate, and medications, the augmentation index was significantly higher in patients with paroxysmal AF than in subjects without paroxysmal AF (means +/- SE: 88.9 +/- 1.0 and 81.8 +/- 1.0%, respectively; p < 0.001). In all subjects, an increase in the augmentation index was significantly correlated with LV hypertrophy and left atrial enlargement. Multiple logistic analysis revealed that an increase in the augmentation index was significantly related with paroxysmal AF, and the adjusted odds ratio of paroxysmal AF was approximately 1.8 for each 10% augmentation index increase (p < 0.01). CONCLUSION: An increase in the augmentation index was independently associated with paroxysmal AF. This result suggests that enhanced wave reflection may be related to the development of AF.


Subject(s)
Atherosclerosis/physiopathology , Atrial Fibrillation/physiopathology , Blood Pressure/physiology , Hypertension/physiopathology , Pulsatile Flow/physiology , Aged , Atrial Fibrillation/diagnostic imaging , Chronic Disease , Echocardiography , Female , Humans , Male , Middle Aged , Multivariate Analysis , Ventricular Function, Left/physiology
4.
Clin Exp Hypertens ; 25(3): 145-54, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12716077

ABSTRACT

Blood pressure (BP) decay data obtained from homeBP measurements in six patients with uncomplicated essential hypertension treated with a calcium blocker, amlodipine, were fitted to an exponential-exponential cosine function to determine the characteristic BP-lowering effects of amlodipine. An exponential-exponential cosine function fitted the morning and night systolic BP (sBP) decay data better than a simple exponential function. From the coefficients of the equation, the estimated BP lowering, time constant for BP decay and BP oscillation induced by amlodipine for morning and night sBP were approximately 23 and 25 mmHg, 10 and 6 days, and 12 and 12 mmHg, respectively. Diastolic BP showed a similar fitting though the fitting was weaker. The fitting results indicate that the BP decay, especially the sBP decay, induced by amlodipine occurred in an oscillative fashion, and the present analysis using home BP data may provide clinically useful information about the characteristic effects of amlodipine.


Subject(s)
Amlodipine/therapeutic use , Blood Pressure Determination/methods , Blood Pressure/drug effects , Calcium Channel Blockers/therapeutic use , Hypertension/drug therapy , Aged , Amlodipine/pharmacology , Blood Pressure/physiology , Calcium Channel Blockers/pharmacology , Female , Humans , Male , Middle Aged , Models, Theoretical , Self Care/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...